Usman Nassim Insider Trades

Insider Trading History

Track insider trading activity for Usman Nassim. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Gyre Therapeutics
Gyre Therapeutics GYRE
Director
Holding Value $31.5k 5,088 shares
Last Trade
Jun 28, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$41.2k 3,452 shares
$11.93
$6.19
Gyre Therapeutics
Gyre Therapeutics GYRE
Director
Holding Value $1.72M 278,200 shares
Last Trade
Jun 28, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$41.2k 3,452 shares
$11.93
$6.19
Gyre Therapeutics
Gyre Therapeutics GYRE
Director
Holding Value $10.1k 1,636 shares
Last Trade
Jun 28, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$41.4k 3,452 shares
$12.00
$6.19
Gyre Therapeutics
Gyre Therapeutics GYRE
Director
Holding Value $41.7k 6,736 shares
Last Trade
May 01, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$283k 20,000 shares
$14.13
$6.19
Gyre Therapeutics
Gyre Therapeutics GYRE
Director
Holding Value $1.74M 281,652 shares
Last Trade
May 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$277k 20,000 shares
$13.86
$6.19
Gyre Therapeutics
Gyre Therapeutics GYRE
Director
Holding Value $134k 21,636 shares
Last Trade
May 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$277k 20,000 shares
$13.86
$6.19
Gyre Therapeutics
Gyre Therapeutics GYRE
Director
Holding Value $10.1k 1,636 shares
Last Trade
Apr 01, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$323k 20,000 shares
$16.15
$6.19
Gyre Therapeutics
Gyre Therapeutics GYRE
Director
Holding Value $1.87M 301,652 shares
Last Trade
Apr 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$317k 20,000 shares
$15.85
$6.19
Gyre Therapeutics
Gyre Therapeutics GYRE
Director
Holding Value $134k 21,636 shares
Last Trade
Apr 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$317k 20,000 shares
$15.85
$6.19
Gyre Therapeutics
Gyre Therapeutics GYRE
Director
Holding Value $1.99M 321,652 shares
Last Trade
Mar 15, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$335k 20,000 shares
$16.76
$6.19
Gyre Therapeutics
Gyre Therapeutics GYRE
Director
Holding Value $134k 21,636 shares
Last Trade
Mar 15, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$335k 20,000 shares
$16.76
$6.19
Gyre Therapeutics
Gyre Therapeutics GYRE
Director
Holding Value $10.1k 1,636 shares
Last Trade
Mar 15, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$345k 20,000 shares
$17.26
$6.19
Catalyst Biosciences
Catalyst Biosciences CBIO
Director
Holding Value $6.3M 341,652 shares
Last Trade
Oct 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$176k 343,518 shares
$0.51
$18.45
Gyre Therapeutics
Gyre Therapeutics GYRE
Director
Holding Value $11.6k 1,866 shares
Last Trade
Oct 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.38M 343,518 shares
$6.93
$6.19
Catalyst Biosciences
Catalyst Biosciences CBIO
President & CEO
Holding Value $0 0 shares
Last Trade
Aug 31, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$0.56 1 shares
$0.56
$18.45

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up